-
Allergan Gains 1.50% Following Q4 Beat, Company Updates On M&A Activity
Monday, February 22, 2016 - 9:51am | 327Shares of Allergan plc Ordinary Shares (NYSE: AGN) were trading higher by more than 1.50 percent on Monday after the company reported its fourth quarter results. Allergan said that it earned $3.41 per share in the fourth quarter on revenue of $4.2 billion. Wall Street analysts were expecting the...
-
Teva Buys Allergan Unit: How Mylan, Other Biotech Stocks Are Reacting
Monday, July 27, 2015 - 12:08pm | 340Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) surged to new 52-week highs of $69.42 on Monday after the company announced its acquisition of Allergan PLC (NYSE: AGN)'s Generics segment for a total consideration of $40.5 billion. Shares of Allergan also spiked to new 52-...